Article Sidebar

PDF
Date Published: 12/04/2023
Abstract Views: 180
Views PDF: 120
DOI: https://doi.org/10.51298/vmj.v525i1A.4982
Issue
Vol. 525 No. 1A (2023)
Section
Các bài báo
How to Cite
Nguyễn, T. B. ., Phạm , S. N. ., & Nguyễn, V. Q. . (2023). APPLICATION OF BALLOON-OCCLUDED TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA THROUGH THE FIRST CLINICAL CASE IN VIETNAM AND REVIEW OF LITERATURE. Vietnam Medical Journal, 525(1A). https://doi.org/10.51298/vmj.v525i1A.4982

APPLICATION OF BALLOON-OCCLUDED TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA THROUGH THE FIRST CLINICAL CASE IN VIETNAM AND REVIEW OF LITERATURE

Thái Bình Nguyễn1,, Sơn Nam Phạm 1, Văn Quế Nguyễn1
1 Hanoi medical university hospital

Main Article Content

Abstract

chemoembolization for hepatocellular carcinoma is a technique recently mentioned a lot in the reports of Japanese authors. Although balloon-occluded transcatheter arterial chemoembolization was first reported a long time ago but this technique has recently been used more by improvements in micro-balloon catheter. At Hanoi Medical University Hospital, we have successfully performed the first case using micro-balloon catheter in transarterial chemoembolization of hepatocellular carcinoma in Vietnam. Through the clinical case using this method, we want to present our observations and results obtained during the implementation of the technique and summarize the knowledge mentioned in the literature related to balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma.

Article Details

Keywords

Transcatheter arterial chemoembolization, hepatocellular carcinoma, micro-balloon catheter.

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
2. Raoul J-L, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28-36. doi:10.1016/ j.ctrv. 2018.11.002
3. Irie T, Takahashi N, Hoshiai S. Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles. Int J Gastrointest Interv. 2020;9(1):13-18. doi:10.18528/ijgii190025
4. Nakamura H, Tanaka M, Oi H. Hepatic embolization from the common hepatic artery using balloon occlusion technique. Am J Roentgenol. 1985;145(1):115-116. doi:10.2214/ ajr.145.1.115
5. Hatanaka T, Arai H, Kakizaki S. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 2018; 10(7):485-495. doi:10.4254/wjh.v10.i7.485
6. Kakuta A, Shibutani K, Ono S, et al. Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization: Temporal variations in stump pressure. Hepatol Res. 2016;46(5):468-476. doi:10.1111/hepr.12579
7. Matsumoto T, Endo J, Hashida K, et al. Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization. Minim Invasive Ther Allied Technol. 2016; 25(1): 22-28. doi:10.3109/13645706.2015.1086381
8. Kudo M, Ueshima K, Kubo S, et al. Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version): RECICL (2015 revised version). Hepatol Res. 2016;46(1):3-9. doi:10.1111/hepr.12542
9. Hatanaka T, Arai H, Shibasaki M, et al. Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study: Overall response and overall survival after B-TACE. Hepatol Res. 2018;48(2):165-175. doi:10.1111/hepr.12912
10. Arai H, Abe T, Takayama H, et al. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma: B-TACE using miriplatin for HCC. Hepatol Res. 2015; 45(6):663-666. doi: 10.1111/hepr.12403.